Jacob Nwosu
Physician Assistant · Sicklerville, NJNPI 1538496989
Payments from drug & device makers
Across 131 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$707
- Otsuka America Pharmaceutical, Inc.$237
- Johnson & Johnson$177
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$161
- Alkermes, Inc.$145
- Takeda Pharmaceuticals U.S.A., Inc.$116
- plus $480 from 11 others
What the payments were for
- Food & beverage$1,96997%
- Education$553%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$2,024 in reported general payments places this provider in the 85th percentile of 2,726 physician assistant providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 41 | $59,401 |
| VraylarCariprazine Hcl | 26 | $36,431 |
| TrintellixVortioxetine Hydrobromide | 74 | $35,620 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $5,752 |
| BelsomraSuvorexant | 11 | $4,792 |
| Aripiprazole | 86 | $4,097 |
| Vilazodone Hcl | 20 | $4,014 |
| Lisdexamfetamine Dimesylate | 12 | $2,754 |
| Duloxetine Hcl | 59 | $1,227 |
| Bupropion XlBupropion Hcl | 60 | $1,216 |
| Clomipramine Hcl | 32 | $1,041 |
| Trazodone Hcl | 103 | $816 |
| Alprazolam | 58 | $780 |
| Buspirone Hcl | 65 | $772 |
| Clonazepam | 98 | $698 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $237 | $59,40141 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $116 | $41,37287 claims |
| AbbVieVraylar | $707 | $36,43126 claims |
| MerckBelsomra | $27 | $4,79211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,726 physician assistant providers in New Jersey.
Other physician assistant in Sicklerville
- Alexa HetzelEast Windsor$750K
- Nicole Schmid DavisHamilton$148K
- Todd NewmanHoboken$73K
- Patrick McGinnShrewsbury$72K
- Tatiana Dell'aquilaNutley$43K
- Nicole ColucciRiverdale$36K
- Salvatore SciurbaMiddletown$25K
- Jacqueline CristiniEdison$22K
- Mark MazakLakewood$21K
- Andrea BarkerPrinceton$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.